A Study in Healthy Men to Test How Well Different Doses of BI 1839100 Are Tolerated (1490-0003)
NCT05934955 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 24
Last updated 2023-11-08
Summary
The main objectives of this trial are to investigate safety, tolerability and pharmacokinetics (PK) of BI 1839100 in healthy male subjects following oral administration of single rising doses.
Conditions
- Healthy
Interventions
- DRUG
-
BI 1839100
BI 1839100
- DRUG
-
Placebo matching BI 1839100
Placebo matching BI 1839100
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-07-13
- Primary Completion
- 2023-09-25
- Completion
- 2023-10-02
Countries
- Japan
Study Locations
More Related Trials
-
A Study in Healthy Men to Test How Different Doses of BI 1595043 Are Tolerated
NCT04439838 ·Status: COMPLETED ·Phase: PHASE1
-
A Study About How Different Doses of BI 1358894 Are Taken up in the Body and How Well They Are Tolerated in Healthy Japanese Men
NCT03875001 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Men to Test How Well Different Doses of BI 1569912 Are Tolerated
NCT04978506 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Test How Different Doses of BI 1815368 Are Tolerated and How BI 1815368 is Taken up in the Body of Healthy Japanese Men
NCT06494774 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Japanese Men to Test How Well Different Doses of BI 3006337 Are Tolerated
NCT06310005 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability and Pharmacokinetics of Single Rising Oral Doses of BI 1060469 in Healthy Asian Male Volunteers
NCT02183545 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Japanese Men to Test How Well Different Doses of BI 765845 Are Tolerated
NCT06139341 ·Status: COMPLETED ·Phase: PHASE1
-
This Study is Done in Healthy Japanese Volunteers. It Looks at How Different Doses of BI 1015550 Are Taken up in the Body and How Well They Are Tolerated.
NCT03542344 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Test How Well Different Doses of BI 1584862 Are Tolerated by Healthy Men
NCT06006598 ·Status: COMPLETED ·Phase: PHASE1
-
This Study is Done in Healthy Japanese Volunteers. It Looks at How Different Doses of BI 730357 Are Taken up in the Body and How Well They Are Tolerated
NCT03793621 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Japanese and Chinese Men to Test How Well Different Doses of BI 706321 Are Tolerated
NCT05183360 ·Status: TERMINATED ·Phase: PHASE1
-
A Study to Test How Healthy Men Tolerate Different Doses of BI 1595043
NCT04789304 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Japanese Men to Test How Well Different Doses of BI 764198 Are Tolerated
NCT04665700 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability and Pharmacokinetics of Single Rising Oral Doses of BI 137882 in Healthy Male Volunteers
NCT01348165 ·Status: TERMINATED ·Phase: PHASE1
-
This Study Tests BI 1467335 in Healthy Japanese and Caucasian Men. The Study Tests How Different Doses of BI 1467335 Are Taken up in the Body and How Well They Are Tolerated
NCT03159455 ·Status: COMPLETED ·Phase: PHASE1
-
This Study Tests BI 685509 in Healthy Chinese and Japanese Men; the Study Tests How Different Doses of BI 685509 Are Taken up in the Body and How Well They Are Tolerated
NCT03259464 ·Status: COMPLETED ·Phase: PHASE1
-
Single Rising Oral Doses of BI 1021958 in Healthy Chinese and Japanese Male Volunteers
NCT01638598 ·Status: COMPLETED ·Phase: PHASE1
-
This Study is Done in Healthy Japanese Volunteers. It Looks at How Different Doses of BI 705564 Are Taken up in the Body and How Well They Are Tolerated
NCT03747926 ·Status: WITHDRAWN ·Phase: PHASE1
-
A Study in Healthy Japanese Men to Test How Different Doses of BI 690517 Are Taken Up in the Body and How Well They Are Tolerated
NCT03608072 ·Status: COMPLETED ·Phase: PHASE1
-
Single Rising Oral Doses of BI 10773 in Healthy Male Volunteers
NCT02182453 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 456906 in Healthy Male Volunteers
NCT03175211 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Men and Women to Find Out How Well Different Doses of BI 1291583 Are Tolerated
NCT03868540 ·Status: TERMINATED ·Phase: PHASE1
-
A Trial in Healthy Men and Women to Find Out How Well Different Doses of BI 1291583 Are Tolerated
NCT04866160 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Japanese Men to Test How Different Doses of BI 894416 Are Tolerated
NCT04540874 ·Status: TERMINATED ·Phase: PHASE1
-
Evaluation of Safety and Tolerability of Single Rising Doses of BI 473494 in Healthy Subjects
NCT03195088 ·Status: TERMINATED ·Phase: PHASE1